05 AUGUST 2025
LIBERA: a new powerful Cough Assist made by MPR
Lesezeit: 2 Min.
Author: Rosa Sammartano

Introducing the LIBERA Cough Assist Device
We are excited to announce a great addition to our respiratory care portfolio: the LIBERA cough assist device from Medical Products Research (MPR).
As you saw from the complete documentation and pricelist shared in last weeks, LIBERA is an advanced, versatile device for both hospital and homecare. It represents a significant step forward in patient therapy.
Here below the key highlights of the new technology:
-
Advanced Therapeutic Modes: It integrates five distinct therapies into a single device:
-
Cough Assist+
-
EFA® (Expiratory Flow Accelerator)
-
Constant Pressure
-
IPPB (Intermittent Positive Pressure Breathing)
-
Cough Trial
-
-
Patient Versatility: Designed for both adult and pediatric use, with or without an artificial airway.
-
Ready to be connected: A telemetry option for remote monitoring is planned for release by the end of 2025.
The introduction of LIBERA strengthens our market position. We want to assure you that the existing Kalos/Kinex models will remain available to ensure a smooth transition.
Therefore, we encourage you to begin planning for wider LIBERA adoption in 2026, as sharing your targets will help us secure the most advantageous pricing for the Vivisol Group.
The MTP team is available to answer any questions you may have from the documents you received. Please don't hesitate to reach out!